PLX PHARMA INC - COM (PLXPQ)

CUSIP: 72942A107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
2,012,355
Share change
-31,269
Total reported value
$6,514,648
Price per share
$3.22
Number of holders
12
Value change
-$77,538
Number of buys
1
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 72942A107?
CUSIP 72942A107 identifies PLXPQ - PLX PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q2 2020

As of 30 Jun 2020, PLX PHARMA INC - COM (PLXPQ) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,012,355 shares. The largest 10 holders included Park West Asset Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, Heritage Way Advisors, LLC, MILLENNIUM MANAGEMENT LLC, Fayez Sarofim & Co, Cranbrook Wealth Management, LLC, BlackRock Inc., and UBS Group AG. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.